SCHEMBL22985563

SCHEMBL22985563

Cc1cccc(-c2ccc3c(c2)c2cc(-c4cccc(C)c4)ccc2n3-c2cc(C#N)ccc2-c2ccc(-c3ccc(C#N)cc3C(F)(F)F)cc2-n2c3ccc(-c4cccc(C)c4)cc3c3cc(-c4cccc(C)c4)ccc32)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AR P10275 7/20 0.46
KIF11 P52732 1/20 0.34
RORC P51449 1/20 0.34
ENPP1 P22413 1/20 0.34
PDK2 Q15119 2/20 0.33
ELANE P08246 2/20 0.33
PGR P06401 1/20 0.33
CYP2C9 P11712 2/20 0.32
NSD2 O96028 1/20 0.32
KDM4E B2RXH2 1/20 0.32
ALDH1A1 P00352 1/20 0.32
LMNA P02545 1/20 0.32
TP53 P04637 1/20 0.32
CYP1A2 P05177 1/20 0.32
HPGD P15428 1/20 0.32
TSHR P16473 1/20 0.32
MAPK1 P28482 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
TDP1 Q9NUW8 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22985568 0.96 AR (0.43) ARKIF11RORCENPP1PDK2
SCHEMBL22985681 0.96 AR (0.45) ARKIF11RORCENPP1PDK2
SCHEMBL22985334 0.96 AR (0.45) ARKIF11RORCENPP1PDK2
SCHEMBL20848431 0.94 AR (0.43) ARKIF11RORCENPP1ELANE
SCHEMBL22985372 0.93 AR (0.42) ARKIF11RORCENPP1PDK2
SCHEMBL22985678 0.93 AR (0.42) ARKIF11RORCENPP1PDK2
SCHEMBL20849184 0.92 AR (0.46) ARKIF11ENPP1PDK2PGR
SCHEMBL22985423 0.92 AR (0.46) ARKIF11RORCENPP1PDK2
SCHEMBL22985011 0.92 KIF11 (0.36) ARKIF11RORCELANENSD2
SCHEMBL22985257 0.92 PDK2 (0.40) ARKIF11RORCENPP1PDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices CYNORA GMBH (DE) 2021-02-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10919880-B2 Organic molecules, in particular for use in optoelectronic devices OCIAD1, OCIAD2, POU2F1 AR 3541/4885KIF11 525/4885RORC 188/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.